✦ LIBER ✦

Results of a phase I/II clinical trial of fractionated hyperthermia in combination with radiation

✍ Scribed by Haim I. Bicher; Fred W. Hetzel; Taljit S. Sandhu

Publisher: Elsevier Science
Year: 1981
Tongue: English
Weight: 159 KB
Volume: 7
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(81)90231-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical hyperthermia: Results of the ph

Clinical hyperthermia: Results of the phase i clinical trial combining localized hyperthermia with or without radiation (high dose rate and low dose rate)

✍ Michael R. Manning; Thomas Cetas; Max L.M. Boone; Robert C. Miller 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 107 KB

A phase I–II trial of cisplatin, hyperth

A phase I–II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies

✍ Terence S Herman; Maxine S Jochelson; Beverly A Teicher; Pamela J Scott; Jorgen 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 911 KB

Outpatient combination chemoimmunotherap

Outpatient combination chemoimmunotherapy for patients with metastatic melanoma : Results of a Phase I/II trial

✍ Mohammed Kashani-Sabet; Richard W. Sagebiel; Henry E. Collins; Alan B. Glassberg 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## BACKGROUND. Few studies have examined the feasibility, safety, and efficacy of an outpatient biochemotherapy regimen of low dose, subcutaneously administered interleukin-2 (IL-2) for patients with metastatic (Stage IV) melanoma. ## METHODS. Nineteen patients were treated with intravenous cispl

Phase I/II trial of combined 131I anti-C

Phase I/II trial of combined 131I anti-CEA monoclonal antibody and hyperthermia in patients with advanced colorectal adenocarcinoma

✍ Bharat B. Mittal; Michael A. Zimmer; Vythialingam Sathiaseelan; Al B. Benson III 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 939 KB

BACKGROUND. This pilot project was undertaken to evaluate the toxicity of and tumor response to combined 13'1 anti-carcinoembryonic antigen monoclonal antibody ('"I anti-CEA RMoAb) and hyperthermia in patients with metastatic colorectal adenocarcinoma.

Phase I clinical trial of bortezomib in

Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors

✍ David P. Ryan; Leonard J. Appleman; Thomas Lynch; Jeffrey G. Supko; Panagiotis F 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

## Abstract ## BACKGROUND. Bortezomib is the first proteasome inhibitor to show preliminary evidence of activity against solid tumors. Findings from preclinical studies prompted a Phase I trial to determine the maximum tolerated dose (MTD) and dose‐limiting toxicities (DLTs) of bortezomib in combi

The conduct of phase I-II clinical trial

The conduct of phase I-II clinical trials in children with cancer

✍ Pratt, Charles B. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 677 KB

Phase I Clinical Trials in children with cancer are carried out with therapeutic intent, so as to define antileukemic/antitumor activity, dose-limiting toxicity, maximum tolerated dosage, and pharmacokinetics. These studies define a dosage of an agent or combination that may be used in a larger stud